Primerica’s Board of Directors approved a $475 million share repurchase program that will run through December 31, 2026. The program allows the company to buy back shares via open‑market transactions, block trades, or private negotiations, subject to market conditions and regulatory constraints.
The new authorization follows a $450 million program that ran through December 31, 2025, and a $375 million program in 2023. As of the third quarter of 2025, Primerica still had about $73.9 million remaining under the prior program, indicating that the company has been actively returning capital to shareholders while maintaining a sizable repurchase balance.
Primerica’s capital position remains robust, with $644.9 million in cash and cash equivalents and a 10 % free‑cash‑flow yield at the end of Q3 2025. The company’s debt‑to‑capital ratio stands at 44.4 %, higher than the industry average but supported by strong cash‑flow generation and a diversified product mix.
In Q3 2025, Primerica reported revenue of $839.85 million, up 7 % year‑over‑year, driven by a 28 % rise in investment and savings products sales and a 5 % increase in term‑life revenue. Adjusted operating earnings per share reached $6.33, up 11 % from the prior year and beating analyst expectations of $5.53 by $0.80, a 14.7 % overrun. The earnings beat was largely attributable to disciplined cost management, a favorable product mix, and sustained demand across the company’s core segments.
CEO Glenn Williams said the company’s “continued strong financial performance across all segments allows us to generate significant deployable capital, underscoring the strength and reliability of our cash flows.” He added that the board’s decision to increase the share‑repurchase program reflects confidence in the business’s ability to generate cash and return value to shareholders, while also supporting earnings per share through share dilution reduction.
Investors have noted the program as a sign of management’s confidence in Primerica’s financial health. The announcement did not trigger a significant immediate market reaction, but it is viewed as a positive step in the company’s broader capital‑allocation strategy, complementing the strong Q3 2025 earnings beat and the company’s ongoing focus on growth and shareholder returns.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.